Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4 instead of v3.3.3. This is a metadata update with no visible changes to the study details or layout; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:01:10.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a Locations section showing the Philadelphia, PA site (Abramson Cancer Center of the University of Pennsylvania) and updated the page revision to v3.3.3; removed the older Pennsylvania Locations entry and the HHS Vulnerability Disclosure link (v3.3.2).
    Difference
    0.3%
    Check dated 2025-12-23T21:04:28.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    - The page revision updated from v3.2.0 to v3.3.2. No study content or data appears to be changed.
    Difference
    0.1%
    Check dated 2025-11-25T10:23:35.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The funding-status banner at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T06:47:52.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    No additions or deletions to core Study Details content were detected for NCT02041260. The page’s primary information, including eligibility criteria and trial details, remains unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T20:38:42.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Update includes a critical operating-status notice and a new software version (v3.2.0) replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:57:50.000Z thumbnail image

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.